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CAMBRIDGE– Thursday, September 19, 2013 – Governor Deval Patrick and the
Massachusetts Life Sciences Center (MLSC) today joined Sanofi and Genzyme
leadership, industry stakeholders and state and local officials to celebrate the grand
opening of  new 112,000-square-foot Global Research and Development facility for
Sanofi in Cambridge. During today’s event, Sanofi also announced a new partnership
and $1-million gift to support student success at the University of Massachusetts-
Boston’s College of Science and Mathematics (CSM). This gift builds on the Patrick
Administration’s efforts to promote public-private partnerships to create workforce
training programs that will prepare the Commonwealth’s students for success in high-
demand fields.
“I thank Sanofi and Genzyme for their continued partnership in growing jobs and
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economic development in the Commonwealth and for the generous contribution to our
UMass Boston students and efforts to ensure that our state’s STEM workforce pipeline
remains strong,” said Governor Patrick. “The new facility builds on our global
leadership in the life sciences and will keep us at the forefront of the innovation
economy for generations to come.”
Headquartered in Paris, Sanofi is an integrated healthcare leader focused on patients’
needs. Sanofi and Genzyme, its Cambridge-based biotechnology company, employ
more than 1,700 researchers from several disciplines and therapeutic areas in Greater
Boston. The new Cambridge facility will house 250 of these employees, who will focus
on oncology and other R&D areas. 
“Our presence at 640 Memorial Drive underscores our belief that together with
physicians, scientists and academics from the Boston area, we can make a real
difference in the lives of patients through developing innovative solutions,” said
Sanofi’s CEO Christopher A. Viehbacher. “It also reinforces our presence in one of the
world’s most vibrant life science ecosystems. We are delighted to further demonstrate
our commitment through our gift to the University of Massachusetts-Boston’s College
of Science and Mathematics. Great science starts with great people and we need to
invest in education for the future.”
Through the MLSC, Massachusetts is investing $1 billion over 10 years in the growth
of the state’s life sciences supercluster. These investments are being made under the
Massachusetts Life Sciences Initiative, passed by the state Legislature and signed into
law by Governor Patrick in 2008. The MLSC awarded Sanofi $2.45 million in tax
incentives in 2010 to support the creation of 100 jobs in Cambridge. Sanofi also joined
the MLSC’s Corporate Consortium to support life sciences innovation in
Massachusetts, contributing a total of $500,000. In 2012, Sanofi acquired Pluromed,
an early-stage life sciences company to which the MLSC awarded a $500,000
Accelerator Loan in 2009. The acquisition triggered repayment of the MLSC’s loan with
interest.
“We are excited to celebrate the official opening of Sanofi’s new cancer research
facilities and their new STEM-focused collaboration with UMass Boston,” said Dr.
Susan Windham-Bannister, Ph.D., President & CEO of the MLSC. “This new office
and lab space will enable Sanofi to continue its groundbreaking R&D efforts in the
fight against cancer, right here in Massachusetts. Sanofi and Genzyme have both
played a significant role in making Massachusetts the global leader in life sciences,
and now they are further enabling our state to strengthen and retain this position by
supporting the industry’s workforce pipeline through the new UMass Boston
partnership.”
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